late-stage study – Talk Bio

Actionable Insights Powered by AI

LEO Pharma’s Acquisition of Timber Pharmaceuticals’ Assets Faces Setback Due to Late-Stage Study Failure

8 months ago talkbio0Tagged Acquisition (action), asset, Congenital ichthyosis, Failure (biologic function), late-stage study, Panthera leo, Pharma, Timber, TMB-001

LEO Pharma, Timber Pharmaceuticals, TMB-001, congenital ichthyosis, late-stage study failure, asset acquisition

Pfizer Temporarily Suspends Dosing in Advanced Duchenne Muscular Dystrophy (DMD) Trial After Patient Fatality

12 months ago talkbio0Tagged Clinical Trials, concerns, DMD, dosing, Duchenne, Evaluation, halt, late-stage study, Muscular Dystrophy, Muscular Dystrophy, Duchenne, Pfizer, Safety, Suspensions, Transitory

Pfizer, Duchenne Muscular Dystrophy (DMD), clinical trial, dosing halt, patient death, late-stage study, temporary suspension, safety concerns, investigation.